Thyroid disease and lipids

Thyroid

Volumn 12, Issue 4, 2002, Pages 287-293

  Duntas, Leonidas H ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; ISOPROTEIN; LIPID; LIPOPROTEIN A; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXYGEN; THYROTROPIN; THYROXINE;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIUM LESION; ENZYME ACTIVITY; EXCRETION; FREE THYROXINE INDEX; GENETIC POLYMORPHISM; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID METABOLISM; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; VASCULAR RESISTANCE;

EID: 0036229326     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250252949405     Document Type: Review

References (78)

1. Blood cholesterol values in hyperthyroidism and hypothyroidism
2. Serum lipids in hypothyroidism
3. Hippocrates complete works. General medicine. Kaktos
4. Lipoprotein-thyroid hormone interactions
5. Metabolic changes in hypothyroidism
6. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein lipase activity in overt hypothyroidism: The effect of substitution therapy
7. Plasma lipids and lipoproteins
8. Lipoproteins metabolism in hepatic lipase deficiency: Studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein
9. Plasma cholesteryl ester transfer protein
10. Hepatic lipase and the clearing reaction: Studies in euthyroid and hypothyroid subjects
11. A new serum type system in man: The Lp system
12. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis
13. Serum lipids and apolipoproteins A-I, A-II and β in primary hypothyroidism before and during treatment
14. Serum lipids in hyper- and hypothyroidism before and after treatment
15. Stimulation of hepatic β-hydroxy-methyl-glutaryl Coenzyme A reductase activity in hypophysectomized rats by L-triiodothyronine
16. Binding of thyroxine hormone to human plasma lipoprotein
17. Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL: An additional mode of entry of thyroxine into cells
18. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase and low density lipoprotein receptor in rats
19. Serum high-density lipoprotein cholesterol concentrations in hypo- and hyperthyroidism
20. Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism
21. Regulation of cholesteryl ester transfer protein (CETP) activity: Review of in vitro and in vivo studies
22. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man
23. Lipoprotein (a) modulation of endothelial surface fibrinolysis and its potential use in atherosclerosis
24. Has lipoprotein 'little' (a) shrunk?
25. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a)
26. Lipoprotein (a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects
27. Interindividual variation in the partition of lipoprotein (a) into lipoprotein subfractions
28. Long term thyroid replacement therapy and levels of lipoprotein (a) and other lipoproteins
29. Changes in Lipoprotein (a) levels in overt and subclinical hypothyroidism before and during treatment
30. Thyroid hormone action on intermediary metabolism
31. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene
32. Progression and regression of human coronary atherosclerosis - The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth
33. The aging thyroid: Thyroid deficiency in the Framingham study
34. The spectrum of thyroid disease in a community: The Whickham survey
35. Thyroid function and serum lipids in older women: A population-based study
36. Hyperlipidaemia in patients with primary and secondary hypothyroidism
37. 131I-low-density lipoproteins in hypothyroidism and thyrotoxicosis
38. Structure and regulation of the LDL receptor and its gene
39. Atrophic thyroiditis, hypertension and coronary heart disease
40. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: Does it mean occult hypothyroidism?
41. The relationship between serum cholesterol and serum thyrotropin, thyroxine, and tri-iodothyronine concentrations in suspected hypothyroidism
42. Plasma triglyceride metabolism in thyroid disease
43. Type III hyperlipoproteinemia: The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
44. Aggravation of broad β-disease in hypothyroidism
45. Expression of type III hyperlipoproteinemia in a subject with secondary hypothyroidism bearing the apolipoprotein E 2/2 phenotype
46. Adrenergic regulation of lipolysis in human adipocytes: Findings in hyper- and hypothyroidism
47. Familial hypercholesterolaemia and hypothyroidism: Coexistence of both disorders in a young woman with severe hypercholesterolaemia
48. Lipoprotein composition in hypothyroidism
49. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation
50. Effect of thyroxine on low-density lipoprotein oxidation. Another thyroid hormone nongenomic effect
51. Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after 1-thyroxine therapy
52. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene
53. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes
54. Thyroxine replacement therapy and circulating lipid concentrations
55. Thyroid hormone and the cardiovascular system
56. Cardiovascular manifestations of endocrine disease
57. Thyroid hormone therapy in cardiovascular disease
58. Thyroid disease and hypertension
59. Lipoproteins, lipolytic enzymes and hormonal status in hypothyroid women at different levels of substitution
60. Atherosclerosis and the thyroid
61. Report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults
62. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
63. The Colorado thyroid disease prevalence study
64. LDL/HDL-changes in subclinical hypothyroidism: Possible risk factors for coronary heart disease
65. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues
66. Decreased HDL cholesterol in subclinical hypothyroidism: The effect of 1-thyroxine therapy
67. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: A need for case-finding
68. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism
69. Low-density lipoprotein cholesterol in subclinical hypothyroidism
70. Flow mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism and high normal serum thyrotropin (TSH) values
71. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options
72. Effect of the thyroid state on myocardial contractility and ventricular ejection rate in man
73. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging
74. Cardiovascular and atherogenic aspects of subclinical hypothyroidism
75. Peripheral responses to thyroid hormone before and after 1-thyroxine therapy in patients with subclinical hypothyroidism
76. L-thyroxine therapy in subclinical hypothyroidism: A double-blind, placebo-controlled trial
77. Effect of thyroid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: A reanalysis of intervention studies
78. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study